CJC-1295 No Dac Ipamorelin Blend

Description CJC-1295 No Dac Ipamorelin Blend Peptide Vials CJC-1295 No DAC Ipamorelin is available in two research-grade variants: The 4mg Blend contains 2 mg of CJC-1295 No DAC and 2 mg of Ipamorelin, totaling 4 mg. The 8mg Blend contains 4 mg of CJC-1295 No DAC and 4 mg of Ipamorelin, totaling 8 mg. MOD GRF 1-29/CJC-1295 No Dac CAS Number 86168-78-7 Molar Mass 3357.93 g·mol⁻¹ Chemical Formula C149H246N44O42S IUPAC Name L-Tyrosyl-L-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-asparaginyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucylglycyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-methionyl-L-seryl-L-argininamide Ipamorelin CAS number 170851-70-4 Molar Mass 711.868 g·mol⁻¹ Chemical Formula C38H49N9O5 IUPAC Name (2S)-6-Amino-2-[[(2R)-2-[[(2R)-2-[[(2S)-2-[(2-amino-2-methylpropanoyl)amino]-3-(4H-imidazol-4-yl)propanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-3-phenylpropanoyl]amino]hexanamide Introduction The CJC-1295 No Dac Ipamorelin Research Blend is a combination of two peptides designed exclusively for research purposes. These peptides, CJC-1295 No DAC and Ipamorelin, are of interest to researchers exploring their potential synergistic effects and individual characteristics. Key Characteristics CJC-1295 No DAC is known for stimulating growth hormone release, which may have anti-aging implications in research settings. Ipamorelin is recognized for its role in stimulating growth hormone secretion and its potential impact on weight gain. Note: Researchers conducting studies on growth hormone secretagogues may also examine the Renew Spray, which combines CJC-1295 (no DAC) and Ipamorelin in a format designed for experimental use. The Regenerate Spray includes an additional peptide, Epithalon, for broader investigative applications. For studies requiring a single-agent format, the Ipamorelin Peptide remains a standard research material. Research Applications This research blend is formulated for scientific investigations focused on understanding the properties and effects of CJC-1295 No Dac and Ipamorelin. Researchers may explore their potential synergies and individual characteristics in various research models. Research Benefits Potential for Synergistic Effects Researchers aim to investigate whether the combination of CJC-1295 No Dac and Ipamorelin may exhibit synergistic effects, enhancing growth hormone-related outcomes. Ipamorelin and Weight Gain Studies suggest that Ipamorelin may influence weight gain by impacting growth hormone release. Researchers may explore this in relevant models. CJC-1295 No DAC: Anti-Aging and Tissue Repair CJC-1295 No Dac has been studied for its potential anti-aging effects and tissue repair properties. Research endeavors may focus on elucidating these benefits in various contexts. Disclaimer This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE. All clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with Institutional Animal Care and Use Committee (IACUC) directives and adhere to Animal Welfare Act (AWA) standards. Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made. Upon finalizing your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. If you are dissatisfied with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected]. IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization. References Lall S, Tung LY, Ohlsson C, Jansson JO, Dickson SL. Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues. Biochem Biophys Res Commun. 2001 Jan 12;280(1):132-8. doi: 10.1006/bbrc.2000.4065. PMID: 11162489. [Read More]. Timms, M, Ganio, K, Forbes, G, Bailey, S, Steel, R.  An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma.  Drug Test Anal. 2019; 11: 804–812. https://doi.org/10.1002/dta.2554. [Read More].